Clinical Trial Update: Erythropoietin in HIE Neonate [EARLY_Phase 1]

View source ↗

Summary

An early-phase Phase 1 trial evaluating erythropoietin for neonatal hypoxic ischemic encephalopathy is sponsored by Assiut University. The study is not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Hypoxic Ischemic Encephalopathy

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Assiut University | Conditions: Neonatal Hypoxic Ischemic Encephalopathy | EARLY_Phase 1 | Status: NOT_YET_RECRUITING